ATLANTA -- A tapered and pulsed course of vancomycin was not significantly better than a standard course of the drug for ...

Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...

Antibiotic-resistant superbugs pose a growing global health threat, with WHO reporting that antimicrobial resistance is ...

Common infections are becoming harder – and sometimes impossible – to treat, the UN World Health Organization (WHO) warned on ...

ATLANTA -- For patients with cardiovascular implantable electronic device (CIED)-associated infections, a shorter course of ...

Dangerous infections that no longer respond to antibiotics are spreading quickly around the world, increasing by as much as 15% a year.

WHO reports that one in six bacterial infections are resistant to antibiotics. The misuse and overuse have accelerated ...

Since the 1940s, antibiotics have been our primary weapon against harmful bacterial infections. But some stubborn pathogens, ...

New data presented at IDWeek 2025 by Japanese drugmaker Shionogi highlight the real-world effectiveness of cefiderocol in ...

The antibiotic EVG7, developed in Leiden, has proven capable of fighting the dangerous gut bacterium C. difficile with only a ...

Under the terms of a deal that rescued the once-rejected tebipenem HBr, GSK will file for approval of the oral antibiotic. Back in 2022, after the FDA requested another phase 3 trial and denied ...

Building on work by Hiroyuki Osada’s group, which reported that the antibiotic hygromycin B induced fungal metabolites in one ...